Report Store

European Markets for Transcatheter Cardiovascular Therapy

362 Pages | 114 Exhibits | 2001 Analysis | Forecasts Through 2005
Despite scientific advancement in the understanding and management of cardiovascular disease, it remains the leading health problem in the European countries covered by this report: the Benelux nations of Belgium, The Netherlands, and Luxembourg; France; Germany; Italy; Spain; and the United Kingdom. Currently, more than 75 million people in these countries (more than 27% of the adult population) exhibit one or more types of cardiovascular disease. At the same time, the national incidence and p...

European Markets for Arrhythmia Management Products

278 Pages | 76 Exhibits | 2001 Analysis | Forecasts Through 2005
Heart disease is the world's leading cause of death for both men and women among all racial and ethnic groups. Each year, arrhythmia disease claims approximately 400,000 lives and costs up to $30 billion in combined healthcare spending in France, Germany, Italy, Spain, and the United Kingdom. In 1999, cardiac rhythm management devices were used in more than 683,000 elective and emergency arrhythmia procedures on patients in these European countries. As life expectancies in the Western Europea...

U.S. Markets for Drug and Fluid Delivery Devices

253 Pages | 73 Exhibits | 2001 Analysis | Forecasts Through 2005
Pharmacological therapy is the preferred treatment method for the management of virtually all common medical disorders that warrant therapeutic intervention. To date, the Food and Drug Administration has cleared approximately 37,000 prescription drug products for marketing in the U.S. These products account for more than 70% of the national consumption of pharmaceuticals. In the year 2000, U.S. pharmacies processed approximately 2.7 billion prescriptions; total sales of prescription and over-...

New Strategies in Cardiovascular Disease Management Programs

139 Pages | 24 Exhibits | 2001 Analysis |
According to the Centers for Disease Control and Prevention, more than 90 million Americans live with some form of chronic disease, accounting for more than 60% of the nation's healthcare spending. With large expenses at stake, payers have recognized the need to focus on the cost-effective management of chronic cardiovascular disease. Over the last decade, progress has been made in the introduction and implementation of cardiovascular disease management programs in terms of growing acceptance...

U.S. Markets for Clinical Laboratory Products

451 Pages | 96 Exhibits | 2001 Analysis | Forecasts Through 2005
In conjunction with the on-going evolution of healthcare delivery in the U.S., the clinical laboratory products market has also undergone broad restructuring. Suppliers are facing an increasingly challenging environment due to changing customer requirements. Although cost containment is the overriding determinant driving change in the industry, other considerations that are playing important roles include the need to maintain the quality of healthcare in the face of reduced resources; the impa...

European Markets for Clinical Laboratory Products

487 Pages | 106 Exhibits | 2001 Analysis | Forecasts Through 2005
The European clinical laboratory products market is both highly competitive and overcrowded, with many competitors supplying similar products. Although the overcrowding has been alleviated somewhat by a spate of mergers, acquisitions, and partnerships, suppliers still face an increasingly challenging environment in which to do business. Cost containment is the overriding determinant driving change in the industry, but other considerations that are playing important roles include the pressure t...

Japanese Markets for Wound Management Products

180 Pages | 54 Exhibits | 2001 Analysis | Forecasts Through 2005
Japan is one of the most densely populated countries in the world. The nation's 125 million inhabitants live within an area the size of Norway or California. For many years, Japan had a booming economy, and the country was considered one of the most productive markets in the world; however, in the early 1990s, Japan's economy slumped, resulting in severely depressed economic conditions throughout the country. Despite action by the Japanese government to improve the situation, the economy has...

Strategic Growth Opportunities in Cardiovascular Interventional Product Markets, 2000-2010

200 Pages | 60 Exhibits | 2000 Analysis | Forecasts Through 2010
This report is a detailed market and technology assessment and forecast of the current and emerging products in interventional cardiology. The report addresses the current state of development of these technologies, including an assessment of the market size and competitor shares for companies with products on the market. The report assesses current status and outlook for development of the technologies, products and markets, providing a ten-year forecast of the evolution of the market describi...

Osteoporosis Products: Opportunities and Trends in U.S. Markets

139 Pages | 46 Exhibits | 2000 Analysis | Forecasts Through 2004
Osteoporosis is the loss of bone mineral density, which contributes to weakened bone tissue and a propensity for fractures, and is one of the major contributors to orthopedic injuries, especially in women. Although the disease is not restricted to women, and many factors contribute to the cause of osteoporosis, the most significant factor for women is menopause. The population of postmenopausal women is rapidly increasing as the baby boom generation reaches middle age, and demographics is expe...

Opportunities in U.S. Gynecological Medicine Markets

502 Pages | 142 Exhibits | 2000 Analysis | Forecasts Through 2004
Gynecological medicine products represent a major, dynamic, and rapidly growing market in the U.S. Factors driving this market include the aging of the female population, accompanied by advances in medical treatments for conditions that affect adult women of all ages. This has resulted in greatly increased demand for healthcare products for the management of benign uterine conditions, contraception, incontinence, infertility, and osteoporosis. New pharmaceutical compounds are expected to enj...

U.S. Gynecology, Clinician Survey

224 Pages | 105 Exhibits | 2000 Analysis |
Gynecology encompasses a variety of medical concerns, conditions, and procedures that approach the horizontal scope of primary care--many women consider their gynecologist to be their primary care physician--while simultaneously providing the vertical depth of a specialty via its interventional caseloads. With both the scope of services offered and large number of practitioners, gynecologists make an attractive target for medical companies. This report from Medtech Insight provides clients...

European Markets for Cardiovascular Diagnostics, 2000-2005

400 Pages | 102 Exhibits | 2000 Analysis | Forecasts Through 2005
Cardiovascular diseases impose a heavy socioeconomic burden on European healthcare systems. In the five largest European countries, France, Germany, Italy, Spain, and the United Kingdom, a total of $110 to $115 billion is spent annually for the management of cardiovascular disorders. Of this total, approximately $40 billion is spent for treating coronary heart disease, more than $15 billion for stroke, $12 billion for hypertensive disease, and approximately $8 billion for congestive heart fai...

Opportunities in U.S. Markets for Neonatal/Perinatal Monitoring and Treatment Products

324 Pages | 114 Exhibits | 1999 Analysis | Forecasts Through 2003
One of neonatal/perinatal medicine's major goals is to develop techniques that increase the survivability of newborns at risk from disease, congenital disorders, or abnormal conditions of birth. The development of these techniques and the products required to deliver them are the focus of this report from Medtech Insight. The demand for neonatal and perinatal products and services is driven by two factors-the number of annual births, and the share of those births that require an increased le...